(Q47913323)

6 February 2018

title

Prodrug chemotherapeutics bypass p-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivity. (English)

1 reference

6 February 2018

1 reference

Veronique Guillemard

1

1 reference

6 February 2018

H Uri Saragovi

series ordinal

2

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 February 2018

published in

Oncogene

1 reference

6 February 2018

volume

23

1 reference

6 February 2018

page(s)

3613-3621

1 reference

6 February 2018

issue

20

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207463

exact match

0 references

cites work

Disabling receptor ensembles with rationally designed interface peptidomimetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Natural products in anticancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Novel peptide conjugates for tumor-specific chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Taxol stabilizes microtubules in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Carcinoembryonic antigen, a human tumor marker, cooperates with Myc and Bcl-2 in cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Multidrug resistance transporters and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Disabling erbB receptors with rationally designed exocyclic mimetics of antibodies: structure-function analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

1 reference

7 January 2021

HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Promotion of microtubule assembly in vitro by taxol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Smart drugs: tyrosine kinase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207463

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207463

1 reference

6 February 2018

release_n7wv7orumvgmtgldjj75ihydxq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n7wv7orumvgmtgldjj75ihydxq

24 November 2022

mapped directly with Wikidata item

PubMed ID

15034547

1 reference

6 February 2018